This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Harvard College, Tufts University. Active years: 2014-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2018
Title: Innovations of Dariush Mozaffarian
Introduction
Dariush Mozaffarian is a prominent inventor based in Boston, MA (US). He has made significant contributions to the field of metabolic disease research. With a total of 2 patents, his work focuses on innovative approaches to understanding and treating metabolic conditions.
Latest Patents
Mozaffarian's latest patents include the use of trans-palmitoleate in identifying and treating metabolic disease. This invention introduces a novel lipokine, trans-C16:1n7-palmitoleate, which serves as a biomarker for metabolic status. Specifically, low concentrations of trans-C16:1n7-palmitoleate in serum indicate a risk of metabolic disease. Furthermore, administering trans-C16:1n7-palmitoleate to a subject, whether through pharmaceutical, nutraceutical, or other means, positively impacts glucose metabolism.
Career Highlights
Throughout his career, Mozaffarian has worked with esteemed institutions such as Tufts College and Harvard College. His research has been pivotal in advancing the understanding of metabolic diseases and their treatment.
Collaborations
Some of his notable coworkers include Haiming Cao and Gokhan S Hotamisligil. Their collaborative efforts have contributed to the success of his research initiatives.
Conclusion
Dariush Mozaffarian's innovative work in the field of metabolic disease has led to significant advancements in understanding and treatment options. His contributions continue to impact the scientific community and improve health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile